Description
Aptin M 50/500 mg Tablet is a combination medication containing Vildagliptin (50 mg) and Metformin Hydrochloride (500 mg). Vildagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor that enhances insulin secretion and decreases glucagon levels in a glucose-dependent manner. Metformin is a biguanide that improves insulin sensitivity and reduces hepatic glucose production. Together, they help control blood sugar levels in patients with type 2 diabetes mellitus